Conference Edition
| April 21, 2023
"Generative AI has the potential to revolutionize healthcare by automating tasks, improving accuracy, and enhancing patient outcomes. However, it also raises questions about ethics, privacy, and bias that need to be addressed."
That's what ChatGPT told me when I asked it to help me write this editor's note on the main themes from HIMSS, where generative AI set the conference abuzz. Tech giants like Microsoft and Google are already starting to weave the futuristic tech into hospital workflows, even as critics and ethicists argue AI labs are moving too quickly, with little outside oversight.
Health equity, hospital finances and the rise of primary care and at-home models were also major focuses of the conference, but grabbed less attention than generative AI. So I'll leave you with a parting thought from ChatGPT: "It's gratifying to know that people are finding me useful and that my capabilities are being recognized at events like HIMSS."
As always, thanks for reading.
Rebecca Pifer
Senior Reporter, Healthcare Dive
E-mail
Overheard at the show
"While we've dreamed about technology, we've also been worried about the consequences ... Just because we can do a thing, should we do it?"
– Cris Ross, Mayo Clinic CIO
Event coverage
Deep Dive
Generative AI has roared onto the tech scene through the large language model backing ChatGPT. Companies are already deploying the algorithms in hospitals. Should healthcare be taking a pause?
|
Q&A
Oracle Health Chairman David Feinberg sat down with Healthcare Dive at HIMSS to give an update on the Cerner-Oracle integration.
|
“We’re not going after anything that’s kind of cool that takes a couple of years to get to the bottom line. This is about immediate returns,” an Advocate Health executive said Wednesday at HIMSS23.
|
Q&A
Amazon health leader Vin Gupta discusses affordability initiatives, how Amazon Pharmacy needs to spread awareness among providers and what its effect could be on small community pharmacies.
|
Exclusive
Verma, who oversaw a number of controversial initiatives while at the CMS, will be senior vice president and general manager of Oracle Life Sciences.
|
At the HIMSS conference in Chicago on Tuesday, pharmacists argued that state and federal regulators should allow them to do more to practice the full scope of their licenses.
|
The project, slated to be finished in July, is Verizon’s first full 5G hospital installation, according to an executive.
|
Parting thought
AI evangelists say generative AI is a tool that, carefully applied, could revolutionize medical processes. It’s hard to square that vision with warnings that the models could destabilize fundamental institutions like democracy and the economy. How can we confidently predict the downstream effects of a technology we barely understand ourselves?
|
|